Symbols

AFYA

Afya·NASDAQ

--(--)

AFYA fundamentals

AFYA Q4 2025 Earnings

Afya (AFYA) released its earnings on Mar 12, 2026: revenue was 166.26M (YoY +21.40%), missed estimates; EPS was 0.4097 (YoY +20.96%), beat estimates.

Revenue / YoY

166.26M

+21.40%

EPS / YoY

0.4097

+20.96%

Report date

Mar 12, 2026

AFYA Earnings Call Summary for Q4,2025

Record 2025 Performance: 12% revenue growth to BRL 3.697 billion, 50% EBITDA expansion to BRL 1.680 billion, 45.4% margin.
2026 Guidance: 9% revenue growth, 5-10% EBITDA growth, despite 190bps margin decline due to strategic investments.
Ecosystem Expansion: 301,000 active users, 196,000 paying medical practice solution users, 25,000+ medical students.
Dividend Announcement: BRL 307.4 million (40% of net income), plus BRL 340-380 million CapEx for growth.
ENAMED Mitigation: 2026 intake unaffected; 2027 mock tests to address penalties, targeting 2027 score improvement.

Earnings

EPS

Revenue

Revenue & Expenses

AFYA has released its 2025 Q4 earnings report, with revenue of 166.70M, reflecting a YoY change of 21.42%, and net profit of 32.03M, showing a YoY change of 28.40%. The Sankey diagram below clearly presents AFYA's revenue sources and cost distribution.

Key Indicators

Afya (AFYA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Afya (AFYA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Afya (AFYA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Afya (AFYA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown